Business Context and Reporting Period
This Form 8-K is filed by cbdMD, Inc. for the reporting period of July 1, 2021. The company is incorporated in North Carolina and is designated as an emerging growth company. Its common stock (YCBD) and 8.0% Series A Cumulative Convertible Preferred Stock (YCBDpA) are registered on the NYSE American.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of a corporate event rather than a financial performance statement.
Material Changes
- Public Offering Closing: On July 1, 2021, cbdMD, Inc. announced the closing of its previously announced firm commitment underwriting public offering.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, risk factors, or contingencies beyond the announcement of the offering closing. Further details regarding the offering are referenced in the press release furnished as Exhibit 99.1.
Investor Verification Checklist
- Verify the total proceeds and share count from the closed public offering by reviewing the press release (Exhibit 99.1).
- Confirm the use of proceeds and any underwriting discounts or commissions associated with the offering.
- Review the company's updated capital structure following the issuance of new shares.